RICE group 🧠🧬🔬

Joint Research lab at @BIOMED_UHasselt & @MaastrichtU Repair - CRISPR/cas9 - PDEs-Epigenetics - Multiple Sclerosis - Alzheimer's - "Science for Patients"

[Assia Tiane @TianeAssia]

The last remaining work of my PhD got published today 🥳

In this communication, we highlight the possible effects of long term sample storage on blood DNA methylation patterns. 🧬👩🏻‍🔬

@VanmierloTim @rice_science

https://t.co/usaDEuuE9u

[RICE group 🧠🧬🔬 @rice_science]

Let this be an encouragement to fellow scientists struggling with obtaining the oh so desired significant and positive data. Data from any experiment deserves to be shared with the field 📚 ☀

[RICE group 🧠🧬🔬 @rice_science]

New paper alert 🚨🚨
Check out our most recently published paper, by Lieve van Veggel, about the ongoing search for an EAAT activator.

@VanmierloTim @BIOMED_UHasselt @MaastrichtU @UniLeidenNews
https://t.co/NkV2Coj6Bh

[Rossana Melo @RossanaMelo5]

Happy International Day of Women and Girls in Science! February 11!🔬🧪🧫
#WomenInScience #WomenAndGirlsInScience #WomenInScienceDay #microscopy

[Assia Tiane @TianeAssia]

Excited to present my poster today at the Glia conference in Berlin about our latest publication on DNA methylation and myelination in Multiple sclerosis. 🧠🧬 #glia2023 #myelin @VanmierloTim @rice_science

[Dr. Bieke Broux @BiekeBroux]

📣 JOB ALERT 📣

I'm looking for an enthusiastic PhD student who is passionate about neuro-immunology, to work on an @FWOVlaanderen-funded project at @uhasselt, @BIOMED_UHasselt.

Interested? Check the link: https://t.co/UcfFFZlTme

@BBBelgium_
@y_efis
@yBIS_BE
@EVB_Org

[Universiteit Hasselt @uhasselt]

Doctoraatsonderzoek Melissa Schepers (#UHasselt/ @MaastrichtU) brengt medicijn om #MultipleSclerose te kunnen stoppen weer stapje dichterbij 👇 @BIOMED_UHasselt @GLW_UHasselt
https://t.co/Uy2zN6g0YL

[RICE group 🧠🧬🔬 @rice_science]

Starting off the week on a good note!! 🥳

Check out another one of our newly published papers about how PDE4D isoforms affect neurite elongation, specifically in the context of Alzheimer's disease.

@VanmierloTim @MaastrichtU @BIOMED_UHasselt

https://t.co/cHFkV4B6eD

[RICE group 🧠🧬🔬 @rice_science]

In our team, we have PhD defenses followed by paper publications!🥳

Check out our most recent paper in Acta Neuropathologica about the epigenomic and transcriptomic profile of MS lesions.

Congrats to everyone involved! 👏🏼👏🏼
@TianeAssia

@BIOMED_UHasselt @MaastrichtU

[Tim Vanmierlo @VanmierloTim]

Interested in how methylation regulates myelination in multiple sclerosis lesions? Read our latest paper in Acta Neuropathologica by Assia Tiane et al.

https://t.co/9jIOrajb4X

[Assia Tiane @TianeAssia]

Hora est! 👩🏻‍🎓

Yesterday marked a milestone in my academic career. I successfully defended my thesis “Relieving the epigenetic blockade in progressive MS - making remyelination accessible again”, the result of my joint PhD between @uhasselt and @MaastrichtU.

[RICE group 🧠🧬🔬 @rice_science]

A big congratulations to our Dr. Tiane for defending her thesis titled:
"Relieving the epigenetic blockade in progressive MS - making remyelination accesible again"
Proud of you for this major achievement! 👏🏼👏🏼👏🏼
@BIOMED_UHasselt @MaastrichtU

[RICE group 🧠🧬🔬 @rice_science]

Congratulations to Dr. Melissa Schepers for defending her PhD thesis on PDE4 inhibition: a novel approach to treat demyelinating disorders. 🥂
Proud of you for this major achievement👏🏼
Congratulations 🥳
@MaastrichtU @BIOMED_UHasselt @uhasselt

[RICE group 🧠🧬🔬 @rice_science]

Our team is having a great start to 2023! Check out a preprint of our latest paper on the epigenomic and transcriptomic profile of chronically demyelinated MS lesions 🧠. Well done @TianeAssia!🥳
@biorxivpreprint @BIOMED_UHasselt

[Assia Tiane @TianeAssia]

Excited to share our latest data on the epigenomic and transcriptomic profile of chronically demyelinated MS lesions, recently published as a preprint on bioRxiv. 🧬
@rice_science @VanmierloTim @BIOMED_UHasselt

https://t.co/ERiiLUvrE3

[Assia Tiane @TianeAssia]

Excited to share our latest data on the epigenomic and transcriptomic profile of chronically demyelinated MS lesions, recently published as a preprint on bioRxiv. 🧬
@rice_science @VanmierloTim @BIOMED_UHasselt

https://t.co/ERiiLUvrE3

[BrainBehavImm @BrainBehavImm]

Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis @VanmierloTim @rice_science @PNIRS @ELSneuroscience #OpenAccess #neuroinflammation #ms #MultipleSclerosis
https://t.co/4q1jfctb2y

[RICE group 🧠🧬🔬 @rice_science]

Check out our most recent paper about PDE4 subtype inhibition and its implications for multiple sclerosis.
Congratulations to our Melissa Schepers, well done!!

[Tim Vanmierlo @VanmierloTim]

At the very end of this year, I am excited to share our latest paper @rice_science in Brain, Behavior, and Immunity by Melissa Schepers.
AddThis | Home https://t.co/Rb0HEVl9sl

[Tim Vanmierlo @VanmierloTim]

At the very end of this year, I am excited to share our latest paper @rice_science in Brain, Behavior, and Immunity by Melissa Schepers.
AddThis | Home https://t.co/Rb0HEVl9sl

[BIOMED_UHasselt @BIOMED_UHasselt]

Read about why PDE4 subtype inhibition is a promising strategy for therapy in demyelinating disease. Congrats, @rice_science team!

[BBBelgium @BBBelgium_]

Do not forget to sign up for out #symposium (30.11.2022) and being part of setting up a new #network in #Belgium to bring researchers interested in blood brain barriers together.
#BBBelgium https://t.co/ijfKOrAioj

[An Voets @AnVoets]

Catherine Lubetzki at #ECTRIMS2022 : Remyelination is currently THE major challenge in multiple sclerosis. Luckily we have quite some expertise about this at @BIOMED_UHasselt 😉